"Inactive" ingredients may alter bioavailability of drugs through effects on p-glycoprotein (POP) and CYP3

Clinical Pharmacology and Therapeutics

Volumn 69, Issue 2, 2001, Pages

  Wandel, A C ^a   Kim, R B ^a   Wood, A J J ^a   Stein, C M ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001968476     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)